DR.RAYMOND LABORATORIES,INC – Trademark Portfolio
Entity Type: 03
DR.RAYMOND LABORATORIES,INC holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 14 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ATOPALM, CURECODE, NEUROMIDE, PSORIAPALM, and SPHINGOBRAIN. The owner is based in RUMSON, NJ.
1 OYSTER BAY DR
RUMSON, NJ 07760
Showing of trademarks Trademarks
Trademark Classifications
DR.RAYMOND LABORATORIES,INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does DR.RAYMOND LABORATORIES,INC have?
DR.RAYMOND LABORATORIES,INC has 23 U.S. trademarks filed with the USPTO. Of these, 6 registered, 10 abandoned, 7 cancelled.
What trademark classes does DR.RAYMOND LABORATORIES,INC file in?
DR.RAYMOND LABORATORIES,INC files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are DR.RAYMOND LABORATORIES,INC's most well-known trademarks?
DR.RAYMOND LABORATORIES,INC's registered trademark portfolio includes well-known marks such as ATOPALM, CURECODE, NEUROMIDE, PSORIAPALM, and SPHINGOBRAIN. These are among 6 currently registered trademarks in the portfolio.
What is DR.RAYMOND LABORATORIES,INC's trademark registration success rate?
DR.RAYMOND LABORATORIES,INC has a 26% trademark registration rate, with 6 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.